Gaucher Disease (GD) Drugs Market, Global Outlook and Forecast 2023-2028

Report ID: 1568481 | Published Date: Jan 2025 | No. of Page: 62 | Base Year: 2024 | Rating: 5 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Introduction to Research & Analysis Reports
    1.1 Gaucher Disease (GD) Drugs Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Gaucher Disease (GD) Drugs Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Gaucher Disease (GD) Drugs Overall Market Size
    2.1 Global Gaucher Disease (GD) Drugs Market Size: 2021 VS 2028
    2.2 Global Gaucher Disease (GD) Drugs Market Size, Prospects & Forecasts: 2017-2028
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Gaucher Disease (GD) Drugs Players in Global Market
    3.2 Top Global Gaucher Disease (GD) Drugs Companies Ranked by Revenue
    3.3 Global Gaucher Disease (GD) Drugs Revenue by Companies
    3.4 Top 3 and Top 5 Gaucher Disease (GD) Drugs Companies in Global Market, by Revenue in 2021
    3.5 Global Companies Gaucher Disease (GD) Drugs Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Gaucher Disease (GD) Drugs Players in Global Market
        3.6.1 List of Global Tier 1 Gaucher Disease (GD) Drugs Companies
        3.6.2 List of Global Tier 2 and Tier 3 Gaucher Disease (GD) Drugs Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 by Type - Global Gaucher Disease (GD) Drugs Market Size Markets, 2021 & 2028
        4.1.2 Enzyme Replacement Therapy
        4.1.3 Substrate Reduction Therapy
    4.2 By Type - Global Gaucher Disease (GD) Drugs Revenue & Forecasts
        4.2.1 By Type - Global Gaucher Disease (GD) Drugs Revenue, 2017-2022
        4.2.2 By Type - Global Gaucher Disease (GD) Drugs Revenue, 2023-2028
        4.2.3 By Type - Global Gaucher Disease (GD) Drugs Revenue Market Share, 2017-2028
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Gaucher Disease (GD) Drugs Market Size, 2021 & 2028
        5.1.2 Non-neuronopathic Gaucher Disease
        5.1.3 Neuronopathic Gaucher Disease
    5.2 By Application - Global Gaucher Disease (GD) Drugs Revenue & Forecasts
        5.2.1 By Application - Global Gaucher Disease (GD) Drugs Revenue, 2017-2022
        5.2.2 By Application - Global Gaucher Disease (GD) Drugs Revenue, 2023-2028
        5.2.3 By Application - Global Gaucher Disease (GD) Drugs Revenue Market Share, 2017-2028
6 Sights by Region
    6.1 By Region - Global Gaucher Disease (GD) Drugs Market Size, 2021 & 2028
    6.2 By Region - Global Gaucher Disease (GD) Drugs Revenue & Forecasts
        6.2.1 By Region - Global Gaucher Disease (GD) Drugs Revenue, 2017-2022
        6.2.2 By Region - Global Gaucher Disease (GD) Drugs Revenue, 2023-2028
        6.2.3 By Region - Global Gaucher Disease (GD) Drugs Revenue Market Share, 2017-2028
    6.3 North America
        6.3.1 By Country - North America Gaucher Disease (GD) Drugs Revenue, 2017-2028
        6.3.2 US Gaucher Disease (GD) Drugs Market Size, 2017-2028
        6.3.3 Canada Gaucher Disease (GD) Drugs Market Size, 2017-2028
        6.3.4 Mexico Gaucher Disease (GD) Drugs Market Size, 2017-2028
    6.4 Europe
        6.4.1 By Country - Europe Gaucher Disease (GD) Drugs Revenue, 2017-2028
        6.4.2 Germany Gaucher Disease (GD) Drugs Market Size, 2017-2028
        6.4.3 France Gaucher Disease (GD) Drugs Market Size, 2017-2028
        6.4.4 U.K. Gaucher Disease (GD) Drugs Market Size, 2017-2028
        6.4.5 Italy Gaucher Disease (GD) Drugs Market Size, 2017-2028
        6.4.6 Russia Gaucher Disease (GD) Drugs Market Size, 2017-2028
        6.4.7 Nordic Countries Gaucher Disease (GD) Drugs Market Size, 2017-2028
        6.4.8 Benelux Gaucher Disease (GD) Drugs Market Size, 2017-2028
    6.5 Asia
        6.5.1 By Region - Asia Gaucher Disease (GD) Drugs Revenue, 2017-2028
        6.5.2 China Gaucher Disease (GD) Drugs Market Size, 2017-2028
        6.5.3 Japan Gaucher Disease (GD) Drugs Market Size, 2017-2028
        6.5.4 South Korea Gaucher Disease (GD) Drugs Market Size, 2017-2028
        6.5.5 Southeast Asia Gaucher Disease (GD) Drugs Market Size, 2017-2028
        6.5.6 India Gaucher Disease (GD) Drugs Market Size, 2017-2028
    6.6 South America
        6.6.1 By Country - South America Gaucher Disease (GD) Drugs Revenue, 2017-2028
        6.6.2 Brazil Gaucher Disease (GD) Drugs Market Size, 2017-2028
        6.6.3 Argentina Gaucher Disease (GD) Drugs Market Size, 2017-2028
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Gaucher Disease (GD) Drugs Revenue, 2017-2028
        6.7.2 Turkey Gaucher Disease (GD) Drugs Market Size, 2017-2028
        6.7.3 Israel Gaucher Disease (GD) Drugs Market Size, 2017-2028
        6.7.4 Saudi Arabia Gaucher Disease (GD) Drugs Market Size, 2017-2028
        6.7.5 UAE Gaucher Disease (GD) Drugs Market Size, 2017-2028
7 Players Profiles
    7.1 Sanofi
        7.1.1 Sanofi Corporate Summary
        7.1.2 Sanofi Business Overview
        7.1.3 Sanofi Gaucher Disease (GD) Drugs Major Product Offerings
        7.1.4 Sanofi Gaucher Disease (GD) Drugs Revenue in Global Market (2017-2022)
        7.1.5 Sanofi Key News
    7.2 Shire
        7.2.1 Shire Corporate Summary
        7.2.2 Shire Business Overview
        7.2.3 Shire Gaucher Disease (GD) Drugs Major Product Offerings
        7.2.4 Shire Gaucher Disease (GD) Drugs Revenue in Global Market (2017-2022)
        7.2.5 Shire Key News
    7.3 Actelion Pharma
        7.3.1 Actelion Pharma Corporate Summary
        7.3.2 Actelion Pharma Business Overview
        7.3.3 Actelion Pharma Gaucher Disease (GD) Drugs Major Product Offerings
        7.3.4 Actelion Pharma Gaucher Disease (GD) Drugs Revenue in Global Market (2017-2022)
        7.3.5 Actelion Pharma Key News
    7.4 Pfizer (Protalix)
        7.4.1 Pfizer (Protalix) Corporate Summary
        7.4.2 Pfizer (Protalix) Business Overview
        7.4.3 Pfizer (Protalix) Gaucher Disease (GD) Drugs Major Product Offerings
        7.4.4 Pfizer (Protalix) Gaucher Disease (GD) Drugs Revenue in Global Market (2017-2022)
        7.4.5 Pfizer (Protalix) Key News
    7.5 ISU ABXIS
        7.5.1 ISU ABXIS Corporate Summary
        7.5.2 ISU ABXIS Business Overview
        7.5.3 ISU ABXIS Gaucher Disease (GD) Drugs Major Product Offerings
        7.5.4 ISU ABXIS Gaucher Disease (GD) Drugs Revenue in Global Market (2017-2022)
        7.5.5 ISU ABXIS Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

List of Tables
    Table 1. Gaucher Disease (GD) Drugs Market Opportunities & Trends in Global Market
    Table 2. Gaucher Disease (GD) Drugs Market Drivers in Global Market
    Table 3. Gaucher Disease (GD) Drugs Market Restraints in Global Market
    Table 4. Key Players of Gaucher Disease (GD) Drugs in Global Market
    Table 5. Top Gaucher Disease (GD) Drugs Players in Global Market, Ranking by Revenue (2021)
    Table 6. Global Gaucher Disease (GD) Drugs Revenue by Companies, (US$, Mn), 2017-2022
    Table 7. Global Gaucher Disease (GD) Drugs Revenue Share by Companies, 2017-2022
    Table 8. Global Companies Gaucher Disease (GD) Drugs Product Type
    Table 9. List of Global Tier 1 Gaucher Disease (GD) Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 10. List of Global Tier 2 and Tier 3 Gaucher Disease (GD) Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 11. By Type – Global Gaucher Disease (GD) Drugs Revenue, (US$, Mn), 2021 & 2028
    Table 12. By Type - Gaucher Disease (GD) Drugs Revenue in Global (US$, Mn), 2017-2022
    Table 13. By Type - Gaucher Disease (GD) Drugs Revenue in Global (US$, Mn), 2023-2028
    Table 14. By Application – Global Gaucher Disease (GD) Drugs Revenue, (US$, Mn), 2021 & 2028
    Table 15. By Application - Gaucher Disease (GD) Drugs Revenue in Global (US$, Mn), 2017-2022
    Table 16. By Application - Gaucher Disease (GD) Drugs Revenue in Global (US$, Mn), 2023-2028
    Table 17. By Region – Global Gaucher Disease (GD) Drugs Revenue, (US$, Mn), 2021 & 2028
    Table 18. By Region - Global Gaucher Disease (GD) Drugs Revenue (US$, Mn), 2017-2022
    Table 19. By Region - Global Gaucher Disease (GD) Drugs Revenue (US$, Mn), 2023-2028
    Table 20. By Country - North America Gaucher Disease (GD) Drugs Revenue, (US$, Mn), 2017-2022
    Table 21. By Country - North America Gaucher Disease (GD) Drugs Revenue, (US$, Mn), 2023-2028
    Table 22. By Country - Europe Gaucher Disease (GD) Drugs Revenue, (US$, Mn), 2017-2022
    Table 23. By Country - Europe Gaucher Disease (GD) Drugs Revenue, (US$, Mn), 2023-2028
    Table 24. By Region - Asia Gaucher Disease (GD) Drugs Revenue, (US$, Mn), 2017-2022
    Table 25. By Region - Asia Gaucher Disease (GD) Drugs Revenue, (US$, Mn), 2023-2028
    Table 26. By Country - South America Gaucher Disease (GD) Drugs Revenue, (US$, Mn), 2017-2022
    Table 27. By Country - South America Gaucher Disease (GD) Drugs Revenue, (US$, Mn), 2023-2028
    Table 28. By Country - Middle East & Africa Gaucher Disease (GD) Drugs Revenue, (US$, Mn), 2017-2022
    Table 29. By Country - Middle East & Africa Gaucher Disease (GD) Drugs Revenue, (US$, Mn), 2023-2028
    Table 30. Sanofi Corporate Summary
    Table 31. Sanofi Gaucher Disease (GD) Drugs Product Offerings
    Table 32. Sanofi Gaucher Disease (GD) Drugs Revenue (US$, Mn), (2017-2022)
    Table 33. Shire Corporate Summary
    Table 34. Shire Gaucher Disease (GD) Drugs Product Offerings
    Table 35. Shire Gaucher Disease (GD) Drugs Revenue (US$, Mn), (2017-2022)
    Table 36. Actelion Pharma Corporate Summary
    Table 37. Actelion Pharma Gaucher Disease (GD) Drugs Product Offerings
    Table 38. Actelion Pharma Gaucher Disease (GD) Drugs Revenue (US$, Mn), (2017-2022)
    Table 39. Pfizer (Protalix) Corporate Summary
    Table 40. Pfizer (Protalix) Gaucher Disease (GD) Drugs Product Offerings
    Table 41. Pfizer (Protalix) Gaucher Disease (GD) Drugs Revenue (US$, Mn), (2017-2022)
    Table 42. ISU ABXIS Corporate Summary
    Table 43. ISU ABXIS Gaucher Disease (GD) Drugs Product Offerings
    Table 44. ISU ABXIS Gaucher Disease (GD) Drugs Revenue (US$, Mn), (2017-2022)
List of Figures
    Figure 1. Gaucher Disease (GD) Drugs Segment by Type in 2021
    Figure 2. Gaucher Disease (GD) Drugs Segment by Application in 2021
    Figure 3. Global Gaucher Disease (GD) Drugs Market Overview: 2021
    Figure 4. Key Caveats
    Figure 5. Global Gaucher Disease (GD) Drugs Market Size: 2021 VS 2028 (US$, Mn)
    Figure 6. Global Gaucher Disease (GD) Drugs Revenue, 2017-2028 (US$, Mn)
    Figure 7. The Top 3 and 5 Players Market Share by Gaucher Disease (GD) Drugs Revenue in 2021
    Figure 8. By Type - Global Gaucher Disease (GD) Drugs Revenue Market Share, 2017-2028
    Figure 9. By Application - Global Gaucher Disease (GD) Drugs Revenue Market Share, 2017-2028
    Figure 10. By Region - Global Gaucher Disease (GD) Drugs Revenue Market Share, 2017-2028
    Figure 11. By Country - North America Gaucher Disease (GD) Drugs Revenue Market Share, 2017-2028
    Figure 12. US Gaucher Disease (GD) Drugs Revenue, (US$, Mn), 2017-2028
    Figure 13. Canada Gaucher Disease (GD) Drugs Revenue, (US$, Mn), 2017-2028
    Figure 14. Mexico Gaucher Disease (GD) Drugs Revenue, (US$, Mn), 2017-2028
    Figure 15. By Country - Europe Gaucher Disease (GD) Drugs Revenue Market Share, 2017-2028
    Figure 16. Germany Gaucher Disease (GD) Drugs Revenue, (US$, Mn), 2017-2028
    Figure 17. France Gaucher Disease (GD) Drugs Revenue, (US$, Mn), 2017-2028
    Figure 18. U.K. Gaucher Disease (GD) Drugs Revenue, (US$, Mn), 2017-2028
    Figure 19. Italy Gaucher Disease (GD) Drugs Revenue, (US$, Mn), 2017-2028
    Figure 20. Russia Gaucher Disease (GD) Drugs Revenue, (US$, Mn), 2017-2028
    Figure 21. Nordic Countries Gaucher Disease (GD) Drugs Revenue, (US$, Mn), 2017-2028
    Figure 22. Benelux Gaucher Disease (GD) Drugs Revenue, (US$, Mn), 2017-2028
    Figure 23. By Region - Asia Gaucher Disease (GD) Drugs Revenue Market Share, 2017-2028
    Figure 24. China Gaucher Disease (GD) Drugs Revenue, (US$, Mn), 2017-2028
    Figure 25. Japan Gaucher Disease (GD) Drugs Revenue, (US$, Mn), 2017-2028
    Figure 26. South Korea Gaucher Disease (GD) Drugs Revenue, (US$, Mn), 2017-2028
    Figure 27. Southeast Asia Gaucher Disease (GD) Drugs Revenue, (US$, Mn), 2017-2028
    Figure 28. India Gaucher Disease (GD) Drugs Revenue, (US$, Mn), 2017-2028
    Figure 29. By Country - South America Gaucher Disease (GD) Drugs Revenue Market Share, 2017-2028
    Figure 30. Brazil Gaucher Disease (GD) Drugs Revenue, (US$, Mn), 2017-2028
    Figure 31. Argentina Gaucher Disease (GD) Drugs Revenue, (US$, Mn), 2017-2028
    Figure 32. By Country - Middle East & Africa Gaucher Disease (GD) Drugs Revenue Market Share, 2017-2028
    Figure 33. Turkey Gaucher Disease (GD) Drugs Revenue, (US$, Mn), 2017-2028
    Figure 34. Israel Gaucher Disease (GD) Drugs Revenue, (US$, Mn), 2017-2028
    Figure 35. Saudi Arabia Gaucher Disease (GD) Drugs Revenue, (US$, Mn), 2017-2028
    Figure 36. UAE Gaucher Disease (GD) Drugs Revenue, (US$, Mn), 2017-2028
    Figure 37. Sanofi Gaucher Disease (GD) Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 38. Shire Gaucher Disease (GD) Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 39. Actelion Pharma Gaucher Disease (GD) Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 40. Pfizer (Protalix) Gaucher Disease (GD) Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 41. ISU ABXIS Gaucher Disease (GD) Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
62
Frequently Asked Questions
Gaucher Disease Drugs Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Gaucher Disease Drugs Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Gaucher Disease Drugs Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports